Minerva Neurosciences, Inc.

US$2.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NERVHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (30.23%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.01
PE TTM —
TSR TTM (42.38%)
Mkt cap US$115.5M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.48
2.60%
(77.18%)
Sell 4|12|4|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
9.96%
5.37%
15.72%
9.95%
Revenue$M
9.872
9.887
9.927
9.961
0.62%
3.58%
0.63%
3.94%
Peers (US$115.5M)
Cap (US$)
PE
118.3M
—
115.7M
25.56x
Capital
TTM
5Y
10Y
Leveragex
0.064
0.203
0.200
EBIT/Intx
2.440
0.095
0.115
Own earn%
(86.63)
(76.68)
(77.67)
Sh yield%
39.40
28.15
27.97
Owners
Insiders/Inst%
14.18
80.34
Short interest%
3.18
SBC / revenue%
1.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
4–9
$1 testx
—
Incr. ROIC%
4